Clinical Trial Update: ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

View source ↗

Summary

This clinical trial update reports the termination of a study evaluating ADSTILADRIN (nadofaragene firadenovec) and summarizes its early utilization and real-wo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• ADSTILADRIN (nadofaragene firadenovec)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Bladder Cancer | Status: TERMINATED